Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000950103-20-011915
Filing Date
2020-06-17
Accepted
2020-06-17 20:51:39
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 3A dp130577_3a-coyne.html 3/A  
1 FORM 3A dp130577_3a-coyne.xml 3/A 4304
  Complete submission text file 0000950103-20-011915.txt   5651
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Issuer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ROYALTY PHARMA PLC 110 EAST 59TH STREET NEW YORK NY 10022
Business Address
Coyne Terrance P. (Reporting) CIK: 0001814876 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39329 | Film No.: 20971057